Medis, the leading commercialization company for Central and Eastern Europe (CEE), has entered into a long-term, multi-territorial agreement with ESTEVE for the distribution of 8 specialty medicines across 10 countries in the region. ESTEVE is an international pharmaceutical innovator with a rich Spanish heritage aimed at a purposeful expansion approach worldwide.
Under the agreement, Medis has obtained the distribution rights for specialty medicines in various therapeutic areas.
With Medis’ expertise and experience, ESTEVE will strengthen its presence in Central and Eastern Europe, offering new treatment options to patients,
commented Berta Lozano O’Felan, International Pharma Sales Director at ESTEVE.
We have a bold vision to become an international biopharmaceutical leader in specialty therapeutics, and we are excited to partner with Medis as we take steps towards this goal.
Martina Perharič, Chief Business Officer at Medis, added:
We are thrilled to support ESTEVE in enhancing its presence in the complex and diverse region of Central and Eastern Europe. Leveraging our expertise, we will ensure that ESTEVE's products reach patients even in markets where they were not previously available. We excel at overcoming barriers to efficiently and safely deliver therapies across the CEE region, regardless of whether it is an EU or non-EU country.